Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
2.780
0.00 (0.00%)
At close: Sep 11, 2025, 4:00 PM EDT
2.770
-0.010 (-0.36%)
After-hours: Sep 11, 2025, 7:17 PM EDT
Soligenix Market Cap
Soligenix has a market cap or net worth of $11.91 million as of September 11, 2025. Its market cap has increased by 28.11% in one year.
Market Cap
11.91M
Enterprise Value
7.18M
1-Year Change
28.11%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $11.91M, a decrease of -51.96%. That is a compound annual growth rate of -2.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 11.90M | 75.00% |
Dec 31, 2024 | 6.80M | -13.92% |
Dec 29, 2023 | 7.90M | -59.49% |
Dec 30, 2022 | 19.50M | -31.10% |
Dec 31, 2021 | 28.30M | -25.92% |
Dec 31, 2020 | 38.20M | 27.76% |
Dec 31, 2019 | 29.90M | 96.71% |
Dec 31, 2018 | 15.20M | -21.65% |
Dec 29, 2017 | 19.40M | 128.24% |
Dec 30, 2016 | 8.50M | -72.40% |
Dec 31, 2015 | 30.80M | 42.59% |
Dec 31, 2014 | 21.60M | -37.39% |
Dec 31, 2013 | 34.50M | 414.93% |
Dec 31, 2012 | 6.70M | 1.52% |
Dec 30, 2011 | 6.60M | -83.90% |
Dec 31, 2010 | 41.00M | -11.64% |
Dec 31, 2009 | 46.40M | 660.66% |
Dec 31, 2008 | 6.10M | -62.11% |
Dec 31, 2007 | 16.10M | -2.42% |
Dec 29, 2006 | 16.50M | 20.44% |
Dec 30, 2005 | 13.70M | -49.07% |
Dec 31, 2004 | 26.90M | -0.37% |
Dec 31, 2003 | 27.00M | 167.33% |
Dec 31, 2002 | 10.10M | -22.90% |
Dec 31, 2001 | 13.10M | 3.15% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.05B |
Johnson & Johnson | 423.35B |
AbbVie | 373.91B |
UnitedHealth Group | 314.17B |
AstraZeneca | 250.26B |
Novartis AG | 248.23B |
Novo Nordisk | 244.96B |
Abbott Laboratories | 225.13B |